Essential Partners’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1K Sell
3,850
-10,454
-73% -$26.6K 0.01% 1176
2026
Q1
$28K Buy
14,304
+11,295
+375% +$26.5K 0.01% 799
2025
Q4
$8.15K Buy
3,009
+2,763
+1,123% +$9.07K ﹤0.01% 1243
2025
Q3
$1.04K Buy
246
+153
+165% +$673 ﹤0.01% 2012
2025
Q2
$463 Buy
+93
New +$404 ﹤0.01% 1723

Other funds holding GDRX

Essential Partners's GDRX Position: Q2 2026 in Review

Essential Partners reduced its GoodRx Holdings (GDRX) stake by 73% in Q2 2026, selling an estimated $26.6K and leaving 3,850 shares worth $11.1K. The position accounts for 0.01% of the portfolio, ranked #1176.

Essential Partners first reported a position in GDRX in Q2 2025 and has held it in 5 quarters since. The position peaked at $28K in Q1 2026. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Essential Partners held 3,850 shares of GoodRx Holdings worth $11.1K as of Q2 2026.
  • Essential Partners sold 10,454 GoodRx Holdings shares in Q2 2026, an estimated $26.6K.
  • GoodRx Holdings made up 0.01% of Essential Partners's portfolio in Q2 2026, its #1176 holding.
  • Essential Partners first reported a position in GoodRx Holdings in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's GoodRx Holdings position peaked at $28K in Q1 2026.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.